<DOC>
	<DOCNO>NCT01916863</DOCNO>
	<brief_summary>The purpose study assess effect LX4211 comparator drug canagliflozin intestinal glucose absorption metabolism single dose healthy subject comparison placebo .</brief_summary>
	<brief_title>Study Evaluate Effect Single Doses LX4211 Canagliflozin Intestinal Glucose Absorption Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Adult subject ≥18 ≤55 year age Vital sign Screening follow range : systolic blood pressure , 90140 mmHg ; diastolic blood pressure , 5090 mmHg ; heart rate , 45100 bpm Body mass index ( BMI ) ≥18 ≤35 kg/sq Willing able provide write informed consent Use medication ( prescription , overthecounter , herbal tea , supplement ) within 7 day dose Use investigational agent study treatment within 30 day Day 1 Use protein antibodybased therapeutic agent within 3 month Screening Prior exposure LX4211 canagliflozin Daily use &gt; 5 cigarette tobacco product within 6 week prior Screening participate study History bariatric surgery gastrointestinal surgery may induce malabsorption History bowel resection , malabsorptive disorder , severe gastroparesis , GI procedure purpose weight loss would slow gastric empty History major surgery within 6 month prior Screening History hypersensitivity inactive component LX4211 , inactive component canagliflozin , acetaminophen oral solution inactive component acetaminophen liquid preparation History renal disease significantly abnormal kidney function test History hepatic disease significantly abnormal liver function test History active infection within 30 day prior Day 1 History alcohol substance abuse within 2 year prior Day 1 History hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody ( HCV Ab ) , HIV1 HIV2 Donation loss &gt; 500 mL blood blood product within 56 day Day 1 positive pregnancy test Screening Day 1 Positive urine screen drug abuse Screening Day 1 Positive breath test alcohol Screening Day 1 Inability difficulty swallow whole tablet Unable unwilling communicate cooperate Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>